2021 Cannabinoids Sativa Treatment 
Project CBD
MAY 24, 2023
Ten years ago, most cannabis consumers couldn’t tell a terpene from a cannabinoid. A 2021 study 2 by University of Arizona scientists concluded that certain terpenes are “cannabimimetic” (in a mouse model of cannabis intoxication) and can selectively enhance cannabinoid activity. But today things are different.
Project CBD
JUNE 7, 2023
Project CBD recently reported on studies indicating that cannabis terpenes — the compounds that give the plant its robust and distinctive smell — activate the CB1 cannabinoid receptor. What’s more, in the presence of THC (also a CB1 agonist), terpenes appear to modulate cannabinoid activity in varied and interesting ways.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Project CBD
FEBRUARY 28, 2023
HerbalGram, the acclaimed quarterly journal of the American Botanical Council, recently published its 2021 “Herb Market Report,” which included data on sales of CBD as an herbal ingredient in mainstream and natural retail channels in the United States. in 2021 reached $2 billion, according to Statistica.)
The Cannigma
OCTOBER 2, 2022
Additionally, nausea is a common side effect of cancer treatments, migraines, pregnancy, and more. But what about CBD , which is usually considered the “more medical” cannabinoid? A 2021 study identified the antiemetic properties of CBD but adding CBD to the mix doesn’t seem to provide a clear improvement. CBDA and nausea.
Project CBD
JULY 12, 2023
It was once a common assumption within the cannabis community that plant cannabinoids aren’t “activated” or useful until they are “decarbed” — short for decarboxylated — which refers to the process of heating cannabis before it is consumed. But that notion has proven to be way off the mark. Cannabis roots.
The Cannigma
JANUARY 13, 2023
The authors noted that while “promising data are emerging on the possible role of ECS in migraine…proper placebo-controlled trials are needed to establish a therapeutic role for cannabinoids.” 7 A 2021 study of a medical cannabis cohort reported that high THC / low CBD flower was the most preferred cannabis type in migraine patients.
Cannabis Law Report
SEPTEMBER 12, 2021
September 09, 2021. Steve Sisolak signed Assembly Bill 101, making Nevada the first state to legalize the use of cannabinoids as a veterinary treatment. Steve Sisolak signed Assembly Bill 101, making Nevada the first state to legalize the use of cannabinoids as a veterinary treatment. Earlier this year, Gov.
Expert insights. Personalized for you.
274 
Let's personalize your content